AFIB
Acutus Medical, Inc.
Set alert
0.00 USD 0.00 0.00%
0.0005 Day range 0.0005
0.0001 52-week range 0.0039
- YTD
- -50.00%
- 1 year
- -66.67%
- Open
- 0.0005
- Prev close
- 0.0001
- Mkt cap
- 2.99K
- Vol
- 10.00K
- Avg vol
- 3.31K
- EPS
- -0.15
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0005
- High
- 0.0005
- Forward P/E
- -0.02
- Beta
- 0.04
- Short ratio
- 0.68
- Inst. own
- 22.19%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.11682
- 200-d avg
- 0.289225
- 1y target
- 0.00
Key statistics
- Market cap
- 1.35M
- Enterprise value
- 19.91M
- Trailing P/E
- 0.00
- Forward P/E
- -0.02
- PEG ratio
- 0.00
- Price / sales
- 0.14
- Price / book
- 0.00
- EPS (TTM)
- -0.33
- Beta
- 0.04
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 9.55M
- Revenue growth
- 191.90%
- Free cash flow
- -2.76M
- Total cash
- 19.95M
- Total debt
- 38.47M
- Return on equity
- -34.36%
- Shares outstanding
- 29.72M
- Short % of float
- 1.91%
- 50-day average
- 0.11682
- 200-day average
- 0.289225
Analyst view
Consensus: hold
Hold
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
AFIB Revenue — quarterly 3.63M
AFIB Net income — quarterly -1.62M
AFIB EPS — quarterly -0.06
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -0.03 | — | — |
| Aug 8, 2024 | Jun 1, 2024 | 0.00 | -0.01 | — | — |
| May 9, 2024 | Mar 1, 2024 | 0.00 | -0.07 | — | — |
| Nov 8, 2023 | Sep 1, 2023 | -0.57 | -0.45 | +0.12 | +21.05% |
| Aug 7, 2023 | Jun 1, 2023 | -0.61 | -0.63 | -0.02 | -3.28% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 15, 2022 | Goldman Sachs | main | — | Neutral |
| Jun 23, 2022 | BTIG | main | — | Buy |
| Apr 26, 2022 | BTIG | up | Neutral | Buy |
| Apr 13, 2022 | Goldman Sachs | main | — | Neutral |
| Jan 19, 2022 | BTIG | down | Buy | Neutral |
| Jan 13, 2022 | Canaccord Genuity | down | Buy | Hold |
About Acutus Medical, Inc.
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- acutusmedical.com
News
- Analyzing West Pharmaceutical Services (NYSE:WST) and Acutus Medical (NASDAQ:AFIB)
- Reviewing T2 Biosystems (NASDAQ:TTOO) & Acutus Medical (NASDAQ:AFIB)
- Comparing Carmell (NASDAQ:CTCX) and Acutus Medical (NASDAQ:AFIB)
- Acutus Medical (NASDAQ:AFIB) versus Assure (NASDAQ:IONM) Head to Head Survey
- Financial Analysis: SANUWAVE Health (OTCMKTS:SNWV) vs. Acutus Medical (NASDAQ:AFIB)
- Acutus Medical Reports Full Year 2024 Financial Results
- Acutus Medical Announces Operational Downsizing
- Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results
- Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results
- Acutus Medical Reports First Quarter 2024 Financial Results
Your note
Sign in to keep a note on AFIB — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BONITA DAVID P | Director | Stock Award(Grant) | Jun 14, 2023 | 20,822 |
| ELBARDISSI ANDREW | Director | Stock Award(Grant) | Jun 14, 2023 | 20,822 |
| FLYNN JAMES E | Director | Stock Award(Grant) | Jun 14, 2023 | 0 |
| GARLAND JASON K. | Director | Stock Award(Grant) | Jun 14, 2023 | 22,400 |
| HUENNEKENS R SCOTT | Director | Stock Award(Grant) | Jun 14, 2023 | 529,349 |
| MARZOUK SHADEN | Director | Stock Award(Grant) | Jun 14, 2023 | 20,822 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 9.09% | 2,660,808 | 2.36M | Jun 29, 2023 |
| Orbimed Advisors LLC. | 9.05% | 2,648,386 | 2.35M | Jun 29, 2023 |
| Vanguard Group Inc | 3.90% | 1,140,706 | 1.01M | Jun 29, 2023 |
| Parkman Healthcare Partners LLC | 2.60% | 762,025 | 676.68K | Jun 29, 2023 |
| Renaissance Technologies, LLC | 1.26% | 369,900 | 328.47K | Jun 29, 2023 |
| American Financial Group Inc. | 1.03% | 299,995 | 266.39K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.85% | 835,044 | 741.52K | Jun 29, 2023 |
| Vanguard Extended Market Index Fund | 0.95% | 278,220 | 247.06K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.35% | 103,149 | 87.68K | May 30, 2023 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.27% | 79,500 | 70.60K | Jun 29, 2023 |
| Fidelity Series Total Market Index Fund | 0.09% | 25,878 | 22.00K | May 30, 2023 |
| Fidelity Total Market Index Fund | 0.08% | 22,522 | 19.14K | May 30, 2023 |